Cas NO. 159351-69-6 Everolimus
Everolimus, a derivative of sirolimus, is a kinase drug that interferes with cell communication and prevents tumor cell growth. It is an oral mammalian Sirolimus (mTOR) inhibitor, which was formerly used clinically to prevent rejection after kidney transplantation and Heart transplantation. At present, it can also be used to treat patients with advanced renal cancer who have used two inhibitors of Vascular endothelial growth factor receptor kinase: Sunitinib and Sorafenib, and the side effects are slight.
Purity ： 98%
Appearance： White to off-white solid